The Biological Products industry on FinBizNet covers 5 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 5 |
|---|---|
| Combined market cap | ₹59,055 Cr |
| Median P/E (profitable companies) | 77.7 |
| Median return on equity | -1.1% |
| Companies with latest quarterly results | 3 of 5 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Biocon Limited | ₹56,860 Cr | 120.9 | 1.1% | ₹4,336 Cr | ₹137 Cr | Q1 FY27 |
| Hester Biosciences Ltd | ₹1,905 Cr | 34.5 | 16.6% | ₹77 Cr | ₹95 Cr | Q1 FY27 |
| Zenotech Laboratories Ltd | ₹263 Cr | — | -1.1% | — | — | — |
| Transgene Biotek Ltd. | ₹19 Cr | — | -18.0% | ₹0 Cr | ₹-0 Cr | Q1 FY27 |
| Hindustan Bio Sciences Ltd | ₹7 Cr | — | -9.1% | — | — | — |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 5 listed companies in the Biological Products industry: Biocon Limited, Hester Biosciences Ltd, Zenotech Laboratories Ltd, Transgene Biotek Ltd., Hindustan Bio Sciences Ltd.
By market capitalisation, the largest Biological Products companies are Biocon Limited (₹56,860 Cr), Hester Biosciences Ltd (₹1,905 Cr), Zenotech Laboratories Ltd (₹263 Cr), Transgene Biotek Ltd. (₹19 Cr), Hindustan Bio Sciences Ltd (₹7 Cr).
The 5 Biological Products companies tracked on FinBizNet have a combined market capitalisation of about ₹59,055 Cr.
The median price-to-earnings ratio across 2 profitable Biological Products companies is 77.7, and the median return on equity across the industry is -1.1%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Biological Products industry.